Ozmosi | Thiamine Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Thiamine

Alternative Names: thiamine, thiamin, vitamin b1, vitamin b 1, vitamina b1, tiamina, betalin s, m.v.c. 9+3, m.v.i.-12 adult, mvc plus, infuvite pediatric (pharmacy bulk package), vitaped, m.v.i. adult (pharmacy bulk package), m.v.i. adult, berocca pn, m.v.i.-12 lyophilized, infuvite adult, m.v.i. pediatric, infuvite pediatric, pediatric infuvite multiple vitamins for infusion, adult infuvite multiple vitamins, pediatric infuvite multiple vitamins, infuvite adult multiple vitamins
Clinical Status: Inactive
Latest Update: 2026-01-13
Latest Update Note: News Article

Product Description

Thiamin is a water-soluble vitamin also known as vitamin B1. Its biologically active form, thiamin pyrophosphate (TPP), is a cofactor in macronutrient metabolism. In addition to its coenzyme roles, TPP plays a role in nerve structure and function as well as brain metabolism.  (Sourced from: https://pubmed.ncbi.nlm.nih.gov/25564426/)

Mechanisms of Action: RTI Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral, Intravenous

FDA Designation: *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Daewoong
Company Location: Asia Pacific
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Thiamine

Countries in Clinic: Korea, Spain

Active Clinical Trial Count: 2

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Cardiac Arrest|Huntington Disease

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

2023-508637-14-00

HUNTIAM

P2

Not yet recruiting

Huntington Disease

2025-12-31

2025-05-02

Treatments

NCT04921189

STAR trial

P2

Completed

Cardiac Arrest

2024-12-10

2025-06-12

Primary Endpoints|Study Completion Date|Treatments|Trial Status